title: Dramatic interaction between levothyroxine and lopinavir/ritonavir in a HIV-infected patient.
authors.forename: Maxime
authors.initials: M
authors.lastname: Touzot
authors.forename: Christine Le
authors.initials: CL
authors.lastname: Beller
authors.forename: Fabien
authors.initials: F
authors.lastname: Touzot
authors.forename: Agnès Lillo-le
authors.initials: AL
authors.lastname: Louet
authors.forename: Christophe
authors.initials: C
authors.lastname: Piketty
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D061466:Lopinavir; D008875:Middle Aged; D011744:Pyrimidinones / Q000009:adverse effects; D019438:Ritonavir / Q000009:adverse effects; D013974:Thyroxine / Q000037:antagonists & inhibitors*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir; D013974:Thyroxine